This translocation of CRT or HSPs onto the surface of dying cells is assumed to be a mechanism underlying the increased immunogenicity of the apoptotic tumor cells as this study revealed it for the treated LLC and B16F10 cells during their R2016-induced apoptotic cell death (Fig 4A and 4B). This evidence concerns the gene CALR and neoplasm.